Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Lipopolysaccharide from Pantoea agglomerans** is a component of the cell walls of the bacterium *Pantoea agglomerans*, which is symbiotic with plants like wheat. It is known for its immunomodulatory effects, particularly in activating macrophages and enhancing innate immunity. It is used in health food, skincare products for atopic dermatitis, and as an active ingredient in feeds for stockbreeding and aquaculture due to its ability to activate macrophages and improve various health conditions. Additionally, it promotes wound healing by enhancing keratinocyte migration and has been explored as a mucosal adjuvant for vaccines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lipopolysaccharide from Pantoea agglomerans.